<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Liu QZ</submitter><funding>The Science and Technology Commission of Shanghai Hongkou District</funding><funding>"Special fund for scientific research startup" by Shanghai Fourth People's Hospital</funding><funding>medical engineering of Shanghai Jiao Tong University</funding><pagination>1749-1762</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11145145</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>115(6)</volume><pubmed_abstract>N&lt;sup>6&lt;/sup>-Methyladenosine (m&lt;sup>6&lt;/sup>A) is a important process regulating gene expression post-transcriptionally. Programmed death ligand 1 (PD-L1) is a major immune inhibitive checkpoint that facilitates immune evasion and is expressed in tumor cells. In this research we discovered that Wilms' tumor 1-associated protein (WTAP) degradation caused by ubiquitin-mediated cleavage in cancer cells (colorectal cancer, CRC) under hypoxia was inhibited by Pumilio homolog 1 (PUM1) directly bound to WTAP. WTAP enhanced PD-L1 expression in a way that was m&lt;sup>6&lt;/sup>A-dependent. m&lt;sup>6&lt;/sup>A "reader," Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) identified methylated PD-L1 transcripts and subsequently fixed its mRNA. Additionally, we found that T-cell proliferation and its </pubmed_abstract><journal>Cancer science</journal><pubmed_title>WTAP-induced N&lt;sup>6&lt;/sup>-methyladenosine of PD-L1 blocked T-cell-mediated antitumor activity under hypoxia in colorectal cancer.</pubmed_title><pmcid>PMC11145145</pmcid><funding_grant_id>sykyqd04401 and sykyqd05101</funding_grant_id><funding_grant_id>YG2022QN115</funding_grant_id><funding_grant_id>hongwei2202-19</funding_grant_id><pubmed_authors>Huang ZX</pubmed_authors><pubmed_authors>Qiao GL</pubmed_authors><pubmed_authors>Zhou MJ</pubmed_authors><pubmed_authors>Chen Z</pubmed_authors><pubmed_authors>Zhang N</pubmed_authors><pubmed_authors>Chen JY</pubmed_authors><pubmed_authors>Zhou DH</pubmed_authors><pubmed_authors>Tu XH</pubmed_authors><pubmed_authors>Xie YX</pubmed_authors><pubmed_authors>Liu QZ</pubmed_authors></additional><is_claimable>false</is_claimable><name>WTAP-induced N&lt;sup>6&lt;/sup>-methyladenosine of PD-L1 blocked T-cell-mediated antitumor activity under hypoxia in colorectal cancer.</name><description>N&lt;sup>6&lt;/sup>-Methyladenosine (m&lt;sup>6&lt;/sup>A) is a important process regulating gene expression post-transcriptionally. Programmed death ligand 1 (PD-L1) is a major immune inhibitive checkpoint that facilitates immune evasion and is expressed in tumor cells. In this research we discovered that Wilms' tumor 1-associated protein (WTAP) degradation caused by ubiquitin-mediated cleavage in cancer cells (colorectal cancer, CRC) under hypoxia was inhibited by Pumilio homolog 1 (PUM1) directly bound to WTAP. WTAP enhanced PD-L1 expression in a way that was m&lt;sup>6&lt;/sup>A-dependent. m&lt;sup>6&lt;/sup>A "reader," Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) identified methylated PD-L1 transcripts and subsequently fixed its mRNA. Additionally, we found that T-cell proliferation and its </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jun</publication><modification>2026-06-02T06:09:15.837Z</modification><creation>2026-04-15T03:10:06.799Z</creation></dates><accession>S-EPMC11145145</accession><cross_references><pubmed>38508217</pubmed><doi>10.1111/cas.16136</doi></cross_references></HashMap>